APA
Vianna A. G. D., Lacerda C. S., Pechmann L. M., Polesel M. G., Marino E. C., Scharf M., Detsch J. M., Marques K. & Sanches C. P. (20210624). Improved glycaemic variability and time in range with dapagliflozin versus gliclazide modified release among adults with type 2 diabetes, evaluated by continuous glucose monitoring: A 12-week randomized controlled trial. : Diabetes, obesity & metabolism.
Chicago
Vianna Andre G D, Lacerda Claudio S, Pechmann Luciana M, Polesel Michelle G, Marino Emerson C, Scharf Mauro, Detsch Josiane M, Marques Kleber and Sanches Claudia P. 20210624. Improved glycaemic variability and time in range with dapagliflozin versus gliclazide modified release among adults with type 2 diabetes, evaluated by continuous glucose monitoring: A 12-week randomized controlled trial. : Diabetes, obesity & metabolism.
Harvard
Vianna A. G. D., Lacerda C. S., Pechmann L. M., Polesel M. G., Marino E. C., Scharf M., Detsch J. M., Marques K. and Sanches C. P. (20210624). Improved glycaemic variability and time in range with dapagliflozin versus gliclazide modified release among adults with type 2 diabetes, evaluated by continuous glucose monitoring: A 12-week randomized controlled trial. : Diabetes, obesity & metabolism.
MLA
Vianna Andre G D, Lacerda Claudio S, Pechmann Luciana M, Polesel Michelle G, Marino Emerson C, Scharf Mauro, Detsch Josiane M, Marques Kleber and Sanches Claudia P. Improved glycaemic variability and time in range with dapagliflozin versus gliclazide modified release among adults with type 2 diabetes, evaluated by continuous glucose monitoring: A 12-week randomized controlled trial. : Diabetes, obesity & metabolism. 20210624.